Background: Panax notoginseng has been used as a general tonic agent to invigorate human body for millennia in China and continued to be used until present. Methods: Some chromatographic methods were performed to isolate pure triterpenoids, and their structures were determined by nuclear magnetic resonance (NMR) experiments. Anti-diabetes activities of isolated compounds were evaluated through their inhibitory activity of protein tyrosine phosphatase 1B (PTP1B) enzyme. Results and Conclusion: Three new dammarane-type triterpenoids, notoginsenoside-LX (1), notoginsenoside-LY (2), and notoginsenoside-FZ (3) together with eighteen known compounds were isolated from the Panax notoginseng leaves. The structure-activity relationship of the compounds with dammaranetype triterpenoids and their PTP1B inhibitory activity were also reported. Results showed that compounds 2, 15, 20, and 21 can significantly inhibit the enzyme activity of PTP1B in a dose-dependent manner, with inhibitory concentration 50 (IC 50 ) values of 29.08 mM, 21.27 mM, 28.12 mM, and 26.59 mM, respectively. The results suggested that Panax notoginseng leaves might have potential as a new therapeutic agent for the treatment of diabetes.
Introduction
Panax notoginseng (Chinese ginseng) or "sanqi" is a functional food in China [1] . Based on the United States (US) Dietary Supplement Health and Education Act (DSHEA) of 1994, notoginseng tea or capsules are being sold as over-the-counter dietary supplements in the US health food market [2] . P. notoginseng has been used for many years because of its beneficial anti-inflammatory and blood circulation properties [3, 4] . P. notoginseng also possesses several interesting pharmacological activities, such as anti-aging, antitumor, immunostimulating, and radioresistance activities [5e8] . P. notoginseng belongs to the same genus as Korean ginseng (Panax ginseng Meyer) and American ginseng (Panax quinquefolius L.), and their main components are similar.
Dammarane triterpene saponins are the major bioactive ingredients of P. notoginseng. To date, more than 60 dammarane-type triterpenoids have been obtained from P. notoginseng [9] . The main constituents of these dammarane-type triterpenoids are ginsenosides that contain an aglycone with a dammarane skeleton. In continuing the search for the minor bioactive constituents from P. notoginseng, the leaves of this plant were chemically investigated.
Protein tyrosine phosphatase 1B (PTP1B) is a major nontransmembrane phosphotyrosine phosphatase in classical insulintargeted tissues. PTP1B overexpression can inhibit the increased expression of insulin in insulin-resistant states [10] . A previous report suggested that PTP1B can be used to treat obesity and type-2 diabetes mellitus [11] .
In the present study, 21 dammarane-type triterpenes (3 new and 18 known ones) were isolated from the leaves of P. notoginseng. Besides the isolation and structure elucidation of the new compounds, the inhibitory effects of all compounds on PTP1B activity were evaluated. The current data suggest that some compounds can be developed as antidiabetic agents in future translational studies.
Materials and methods

General experimental procedure
Column chromatography (cc): silica gel (SiO 2 : 300e400 mesh, Qingdao Marine Chemical Group Co., Qingdao, China); macroporous resin D 101 (Tianjin Chemical Co., Tianjin, China); RP C18 silica gel (300e400 mesh, Agela Technologies Co., Tianjin, China); Sephadex LH-20 (Pharmacia Co., Peapack, USA). Optical rotations were measured on a Perkin-Elmer 241MC polarimeter (PerkinElmer Co., Waltham, USA) using methanol (Concord Technology Co., Tianjin, China) as the solvent. Nuclear magnetic resonance (NMR) spectra were recorded with a Bruker ARX-600 (Bruker Co., Karlsruhe, Germany) ( 1 H, 600 MHz; 13 
Extraction and isolation
Air-dried P. notoginseng leaves (35 kg) were extracted with 70% ethanol (2 Â 350 L) and then evaporated under vacuum at 30 C. Ethanol extracts (1.6 kg) were applied on a macroporous resin column (10.5 kg) preconditioned with distilled water. Elution began with water to remove impurities and then with 70% ethanol (100 L) to isolate the saponin fraction, which was dried with a spray dryer to yield the total saponins (1 kg).
The total saponin (1 kg) was fractionated by silica gel column (300 mm Â 1,600 mm, 30 kg) using a gradient of CH 2 Cl 2 /CH 3 OH (7:1 350 LÀ4:1 350 LÀ3:1 350 L) and CH 3 OH (300 L) to obtain 10 fractions, AÀJ. Fraction A (18 g) was subjected to chromatography on silica gel (70 mm Â 800 mm, 400 g) and then eluted with ligarine and acetone in increasing polarity to yield 10 fractions, A1ÀA10, compounds 15 (20 mg), 16 (10 mg), and 17 (20 mg) . Fractions B (20 g), C (25 g), D (23 g), and E (13 g) were subjected to chromatography on silica gel (70 mm Â 800 mm, 500 g) and then eluted with methanol and dichloromethane in increasing polarity to yield seven fractions, B1ÀB7, eight fractions, C1ÀC8, 10 fractions, D1ÀD10, and five fractions, E1ÀE5. Fraction C4 (100 mg) was passed over a Sephadex LH-20 column (30 mm Â 800 mm, 80 g) and then eluted with MeOH (500 mL) to obtain compound 20 (15 mg). Fraction E3 (1 g) was subjected to chromatography on ODS (30 mm Â 150 mm, 50 g) and then eluted successively with solvents of decreasing polarity (MeOH/H 2 O, 4:6 600 mLÀ 6:4 600 mLÀ7:3 600 mLÀ9:1 600 mLÀ1:0 600 mL) to yield seven fractions, E3-1ÀE3-7. Compound 21 (8 mg) was obtained as granulated crystal from E3-6. Fractions F (18 g), G (15 g), H (20 g), and I (20 g) were subjected to chromatography on ODS (50 mm Â 250 mm, 250 g) and then eluted successively with solvents of decreasing polarity (MeOH/H 2 O, 3:7 3 LÀ5:5 3 LÀ7:3 3 LÀ9:1 3 LÀ1:0 3 L) to yield 11 fractions, F1ÀF11, eight fractions, G1ÀG8, seven fractions, H1ÀH7, and eight fractions, I1ÀI8. Compound 1 (10 mg) was obtained as granulated crystal from F-5. Isolation of the following 15 compounds was performed by preparative HPLC: compounds 2 (18 mg; t R 75.0 min), 12 (30 mg; t R 38.9 min), 13 (20 mg; t R 46.8 min), and 14 (60 mg; t R 53.5 min) were isolated from fraction D3 (500 mg) by HPLC system I; compound 18 (4 mg; t R 41.8 min) was isolated from fraction A2 (60 mg) by HPLC system VI; compounds 3 (15 mg; t R 70.3 min), 4 (15 mg; t R 45.8 min), 5 (14 mg; t R 58.9 min), and 6 (14 mg; t R 65.9 min) were isolated from fraction I4 (200 mg) by HPLC system II; compounds 7 (40 mg; t R 33.5 min) and 8 (60 mg; t R 49.6 min) were isolated from fraction H5 (500 mg) by HPLC system III; compounds 9 (8 mg; t R 17.5 min), 10 (70 mg; t R 26.5 min), and 11 (65 mg; t R 33.7 min) were isolated from fraction G6 (1 g) by HPLC system IV; compound 19 (6 mg; t R 122.9 min) was isolated from fraction B2 (40 mg) by HPLC system V. Table 1 ; HRESIMS m/z 937.5097
Notoginsenoside-LX (1)
[MþNa] þ (calculated for C 47 H 78 O 17 Na, 937.5137). Table 1 ; HRESIMS m/z 775.4577 (calculated for C 41 H 68 O 12 Na, 775.4608). 
Notoginsenoside-LY (2)
(
Notoginsenoside-F Z (3)
20(S)-protopanaxadiol 3-O-b-D-xylopyranosyl-(1/2)-b-D-glu- copyranosyl -(1/2)-b-D-glucopyranoside-20-O-a-L-arabinopyr- anosyl-(1/6)-b-D-glucopyranoside (notoginsenoside-F Z ):
Acid hydrolysis of 1, 2, and 3
Solutions of compounds 1, 2, and 3 (5 mg each) in 2M HCl/MeOH (4:1) (8 mL) were stirred at 90 C for 2 hours. After cooling, each reaction mixture was diluted to 30 mL with water and then extracted with CH 2 Cl 2 (30 mL Â 3). The aqueous layer was neutralized with 1M KOH. After concentration, the residue was examined by thin layer chromatography (TLC; n-BuOH/H 2 O/HOAc 3:2:1) and compared with authentic samples [12] . The retention factor (Rf) values of glucose, arabinose, and xylose were 0.38, 0.43, and 0.51, respectively.
Determination of sugar components
Monosaccharide subunits were obtained as described above. The residue was dissolved in pyridine (0.5 mL) and then added to trimethylchlorosilane (0.2 mL) and hexamethyldisilazane (0.5 mL). The mixture was stirred at 20 C for 15 minutes. The mixture was then extracted with CH 2 Cl 2 (2 mL) following the addition of H 2 O (2 mL). The CH 2 Cl 2 layer was examined by GC [12] .
Inhibitory activity against PTP1B assay
The assay buffer (pH 7.4), consisting of 1 mM ethylene diamine tetra acetic acid (EDTA), 50 mM 3,3-dimethyl glutarate, 5 mM glutathione, and 0.5% fetal calf serum (FCS) (not heat inactivated) was adjusted to an ionic strength of 0.15M by the addition of NaCl [13] . Compounds (final concentration ranging from 0 mM to 200 mM) were added to the assay buffers containing PTP1B. The reaction mixtures were allowed to stand at 37 C for 5 minutes following the addition of the compounds. The reaction was started by the addition of p-nitrophenyl phosphate and incubated for another 30 min, and followed by the addition of 5 mL 0.5M NaOH solution to terminate the reaction. The absorbance at 405 nm was recorded using a microplate absorbance reader to test the enzyme activity.
Results and discussion
Structure elucidation of compounds 1À3
Compound 1 was obtained as white amorphous powder. The molecular formula of 1 was deduced to be C 47 H 78 O 17 by positive (Table 1 ). The NMR data for the side-chain moiety of 1 were almost indistinguishable from those of ginsenosides Rh18 [14] . Otherwise, its NMR spectra were closely similar to those of notoginsenoside Fe [15] , except the presence of the ether linkage between C-12 and C-23. In the heteronuclear multiple bond correlation (HMBC) spectrum (Fig. 1) , and C-6 Glc 00 (d c 69.0), which indicated that the C-1 Glc , C-1 Glc 00, and C-1 Ara were linked to C-3, C-20 of the aglycone, and C-6 Glc 00, respectively. Furthermore, the stereochemistry of 1 was confirmed by the nuclear Overhauser effect spectroscopy (NOESY) spectrum (Fig. 1 On the basis of the above analyses, compound 1 could be deduced to be (20S,23R)-3b-hydroxy-12b,23-epoxy-dammar-24- . The NMR data (Table 1) of 2 were closely similar to those of 1. Compared with 1, the shift to upfield of C-3 [À11 parts per million (ppm)] and shift to downfield of C-2 (þ2 ppm) indicated that C-3 of 2 was linked to hydroxyl. Comparison of the NMR data (Table 1 ) of 1 with those of 2 suggested that the only difference was the presence of one additional glucopyranosyl group in 1, and this was supported by the presence of more units of 162 in the molecular formula of 1 than that of 2. Besides, the NMR spectra of 2 were closely similar to those of ginsenoside Mc [16] , except the presence of the ether linkage between C-12 and C-23. All the proton and carbon signals for compound 2 were assigned using 2D NMR spectra (Fig. 1) . Therefore, compound 2 could be established to be (20S,23R)-3b-hydroxy12b,23-epoxy-dammar-24- 
Structure identification of known compounds
The known compounds were identified as notoginsenoside-Fa (4) [15] , ginsenoside-Rb1 (5) [15] , notoginsenoside-Fc (6) [15] , vina-ginsenoside-R7 (7) [18] , ginsenoside-Rc (8) [17] , ginsenoside-Rd (9) [18] , notoginsenoside-Fe (10) [15] , gypenoside-IX (11) 
PTP1B inhibitory activity
The current data (Table 2) suggest that protopanaxadiol (PPD)-type aglycones are more effective than dammarane triperpenoids having more than three sugars and that the presence of sugar moieties reduces the PTP1B inhibitory activity of the compounds. Ginsenosides possess antidiabetic activity, but their mechanisms are different. For example, ginsenoside Rb1 promotes adipogenesis through the regulation of peroxisome proliferatoractivated receptor (PPAR)-g and microRNA-27b, providing a good illustration to explain the antidiabetic effect of the ginsenoside [24] . The total saponins and ginsenoside Rb1 of ginseng stimulate the secretion of glucagon-like peptide-1 (GLP1) in vivo and in vitro, demonstrating an antidiabetic effect [25] . Ginsenoside Re reduces insulin resistance by activating the PPAR-g pathway and inhibiting tumor necrosis factor (TNF)-a production [26] . However, the current study shows that the antidiabetic effects of P. notoginseng may be a result of the inhibitory activity of some ginsenosides against PTP1B.
In the present study, we isolated three new dammarane-type triterpenoids, elucidated as notoginsenoside-LX (1), notoginsenoside-LY (2), and notoginsenoside-F Z (3), along with 18 known compounds from P. notoginseng leaves and all compounds were firstly evaluated for the inhibitory activity against PTP1B. Among the three new dammarane-type triperpenoids, compound 2 showed similar strong activity comparable to the known compounds 20 and 21. These results suggest that P. notoginseng leaves can be used in folk medicine for their antidiabetic property and that dammarane-type triterpenes enable this plant to be utilized for the treatment of diabetes.
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